UTERINE LEIOMYOMA EMBOLISATION

UTERINE LEIOMYOMA EMBOLISATION was reported 19 times

UTERINE LEIOMYOMA EMBOLISATION is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Soluble Guanylate Cyclase Stimulator [EPC] 4 0.0001
1 Prostacyclin Receptor Agonist [EPC] 1 0.0000
2 Provitamin D2 Compound [EPC] 1 0.0000
3 B Lymphocyte Stimulator-specific Inhibitor [EPC] 1 0.0000
4 Phosphodiesterase 5 Inhibitor [EPC] 2 0.0000
5 Prostacycline Vasodilator [EPC] 2 0.0000
6 Nitrate Vasodilator [EPC] 1 0.0000
7 Endothelin Receptor Antagonist [EPC] 2 0.0000
8 Factor Xa Inhibitor [EPC] 2 0.0000
9 Loop Diuretic [EPC] 3 0.0000
10 Estrogen [EPC] 1 0.0000
11 Opioid Agonist [EPC] 1 0.0000
12 Progestin [EPC] 1 0.0000
13 Vitamin D [EPC] 1 0.0000
14 Vitamin B12 [EPC] 1 0.0000
15 HMG-CoA Reductase Inhibitor [EPC] 1 0.0000
16 Vitamin C [EPC] 1 0.0000
17 Proton Pump Inhibitor [EPC] 1 0.0000
18 Tumor Necrosis Factor Blocker [EPC] 1 0.0000